This is a prospective randomised trial studying patients with stage 3 to 5 chronic kidney
disease (CKD) in order to determine the impact of specialised care by nephrologists compared
to guidelines-directed management by primary care physicians (PCP) on: a) prognosis (clinical
outcome), b) planning of renal replacement therapy (RRT) (urgent versus planned initiation
RRT) and c) patient satisfaction.